Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
ProQR Therapeutics N.V. (PRQR) had Free Cash Flow per Share of $-0.13 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.38M |
|
$-15.66M |
|
-- |
|
$2.38M |
|
$18.35M |
|
$-15.97M |
|
$0.31M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.97M |
|
$-15.16M |
|
105.36M |
|
105.36M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$101.80M |
|
$14.11M |
|
$14.11M |
|
$115.91M |
|
$41.03M |
|
-- |
|
$30.87M |
|
$71.90M |
|
$44.00M |
|
$44.00M |
|
$44.00M |
|
107.71M |
|
| Cash Flow Statement Financials | |
$-13.04M |
|
$-0.19M |
|
$-0.36M |
|
$108.16M |
|
$94.91M |
|
$-13.25M |
|
$1.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.48 |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
100.00% |
|
-671.37% |
|
-671.37% |
|
-- |
|
-658.29% |
|
-658.29% |
|
$-13.24M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.46 |
|
194.96 |
|
-35.59% |
|
-35.59% |
|
-13.51% |
|
-35.59% |
|
$0.41 |
|
|
Free Cash Flow per Share |
$-0.13 |
$-0.12 |
|